Abbott Loses Bid To Toss Humira Cancer Suit
Abbott Laboratories has lost a bid to dismiss a lawsuit claiming the pharmaceutical company failed to warn consumers about the lymphoma risk associated with its arthritis drug Humira....To view the full article, register now.
Already a subscriber? Click here to view full article